,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1251045,25517,Comparative Toxicogenomics Database (CTD),Ammonium Chloride,D000643,Ammonium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D000643,7850,IL1R2,https://ctdbase.org/detail.go?type=gene&acc=7850,,,7850,IL1R2,10116,Rattus norvegicus (Norway rat),Ammonium chloride affects the expression of IL1R2 mRNA,,,PMID:16483693,https://www.ncbi.nlm.nih.gov/pubmed/16483693,16483693,,
1,1292267,31429,Comparative Toxicogenomics Database (CTD),Isothiuronium,D007550,Isothiuronium,https://ctdbase.org/detail.go?type=chem&acc=D007550,7299,TYR,https://ctdbase.org/detail.go?type=gene&acc=7299,,,7299,TYR,9606,Homo sapiens (human),Isothiuronium analog results in decreased expression of TYR mRNA,,,PMID:8043013,https://www.ncbi.nlm.nih.gov/pubmed/8043013,8043013,,
2,1388784,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422,VEGFA,9606,Homo sapiens (human),Doxorubicin results in decreased expression of VEGFA protein,,,PMID:17498666|PMID:17627616,https://www.ncbi.nlm.nih.gov/pubmed/17498666|https://www.ncbi.nlm.nih.gov/pubmed/17627616,17498666|17627616,,
3,1388785,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422,VEGFA,9606,Homo sapiens (human),Doxorubicin results in increased expression of VEGFA mRNA,,,PMID:16900372,https://www.ncbi.nlm.nih.gov/pubmed/16900372,16900372,,
4,1389130,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,7431,VIM,https://ctdbase.org/detail.go?type=gene&acc=7431,,,7431,VIM,9606,Homo sapiens (human),[ZH-2 compound results in increased susceptibility to doxorubicin] which results in decreased expression of VIM protein|[doxorubicin co-treated with ZH-2 compound] results in decreased expression of VIM protein,,,PMID:26701723,https://www.ncbi.nlm.nih.gov/pubmed/26701723,26701723,,
5,1389131,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,7431,VIM,https://ctdbase.org/detail.go?type=gene&acc=7431,,,7431,VIM,9606,Homo sapiens (human),Doxorubicin results in increased expression of VIM mRNA,,,PMID:30031762,https://www.ncbi.nlm.nih.gov/pubmed/30031762,30031762,,
6,1389132,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,7431,VIM,https://ctdbase.org/detail.go?type=gene&acc=7431,,,7431,VIM,10090,Mus musculus (house mouse),[doxorubicin co-treated with MT2A protein] results in decreased expression of VIM protein|doxorubicin results in increased expression of VIM protein,,,PMID:16144979,https://www.ncbi.nlm.nih.gov/pubmed/16144979,16144979,,
7,1389133,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,7431,VIM,https://ctdbase.org/detail.go?type=gene&acc=7431,,,7431,VIM,10090,Mus musculus (house mouse),Doxorubicin results in decreased expression of VIM mRNA,,,PMID:16243910,https://www.ncbi.nlm.nih.gov/pubmed/16243910,16243910,,
8,1389134,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,7431,VIM,https://ctdbase.org/detail.go?type=gene&acc=7431,,,7431,VIM,10090,Mus musculus (house mouse),Doxorubicin results in increased expression of VIM mRNA,,,PMID:22016648,https://www.ncbi.nlm.nih.gov/pubmed/22016648,22016648,,
9,1389135,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,7431,VIM,https://ctdbase.org/detail.go?type=gene&acc=7431,,,7431,VIM,10116,Rattus norvegicus (Norway rat),Doxorubicin results in increased expression of VIM protein,,,PMID:10430982|PMID:29474904,https://www.ncbi.nlm.nih.gov/pubmed/10430982|https://www.ncbi.nlm.nih.gov/pubmed/29474904,10430982|29474904,,
10,1389136,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,7431,VIM,https://ctdbase.org/detail.go?type=gene&acc=7431,,,7431,VIM,10116,Rattus norvegicus (Norway rat),Doxorubicin results in increased oxidation of VIM protein,,,PMID:28818578,https://www.ncbi.nlm.nih.gov/pubmed/28818578,28818578,,
11,1389137,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,7431,VIM,https://ctdbase.org/detail.go?type=gene&acc=7431,,,7431,VIM,10116,Rattus norvegicus (Norway rat),Quercetin inhibits the reaction [doxorubicin results in increased expression of VIM protein],,,PMID:29474904,https://www.ncbi.nlm.nih.gov/pubmed/29474904,29474904,,
12,1389617,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,23078,VWA8,https://ctdbase.org/detail.go?type=gene&acc=23078,,,23078,VWA8,9606,Homo sapiens (human),Doxorubicin results in decreased expression of VWA8 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
13,1389618,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,375567,VWC2,https://ctdbase.org/detail.go?type=gene&acc=375567,,,375567,VWC2,9606,Homo sapiens (human),Doxorubicin results in decreased expression of VWC2 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
14,1389619,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,220001,VWCE,https://ctdbase.org/detail.go?type=gene&acc=220001,,,220001,VWCE,9606,Homo sapiens (human),Doxorubicin results in increased expression of VWCE mRNA,,,PMID:30031762,https://www.ncbi.nlm.nih.gov/pubmed/30031762,30031762,,
15,1389620,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,7450,VWF,https://ctdbase.org/detail.go?type=gene&acc=7450,,,7450,VWF,9606,Homo sapiens (human),Doxorubicin results in decreased expression of VWF mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
16,1389621,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,7450,VWF,https://ctdbase.org/detail.go?type=gene&acc=7450,,,7450,VWF,10090,Mus musculus (house mouse),Doxorubicin results in increased expression of VWF protein|[dexrazoxane co-treated with doxorubicin] results in increased expression of VWF protein|dexrazoxane inhibits the reaction [doxorubicin results in increased expression of VWF protein],,,PMID:30517846,https://www.ncbi.nlm.nih.gov/pubmed/30517846,30517846,,
17,1389622,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,51322,WAC,https://ctdbase.org/detail.go?type=gene&acc=51322,,,51322,WAC,9606,Homo sapiens (human),Doxorubicin results in decreased expression of WAC mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
18,1388240,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,5581,PRKCE,https://ctdbase.org/detail.go?type=gene&acc=5581,,,5581,PRKCE,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PRKCE mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
19,1388360,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,9692,PRORP,https://ctdbase.org/detail.go?type=gene&acc=9692,,,9692,PRORP,10116,Rattus norvegicus (Norway rat),"2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PRORP mRNA",,,PMID:23829299,https://www.ncbi.nlm.nih.gov/pubmed/23829299,23829299,,
20,1388967,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,258765,OR5AQ1,https://ctdbase.org/detail.go?type=gene&acc=258765,,,258765,Or5aq1,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR5AQ1 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
21,1388968,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,257954,OR5BB12,https://ctdbase.org/detail.go?type=gene&acc=257954,,,257954,Or5bb12,10116,Rattus norvegicus (Norway rat),"2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of OR5BB12 mRNA",,,PMID:23829299,https://www.ncbi.nlm.nih.gov/pubmed/23829299,23829299,,
22,1388969,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,258385,OR5BH3,https://ctdbase.org/detail.go?type=gene&acc=258385,,,258385,Or5bh3,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR5BH3 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
23,1388970,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,404329,OR5D43,https://ctdbase.org/detail.go?type=gene&acc=404329,,,404329,Or5d43,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR5D43 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
24,1388971,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,259004,OR5K8,https://ctdbase.org/detail.go?type=gene&acc=259004,,,259004,Or5k8,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR5K8 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
25,1388972,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,258927,OR5P4,https://ctdbase.org/detail.go?type=gene&acc=258927,,,258927,Or5p4,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of OR5P4 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
26,1388973,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,545205,OR5V1B,https://ctdbase.org/detail.go?type=gene&acc=545205,,,545205,Or5v1b,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR5V1B mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
27,1389455,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,54726,OTUD4,https://ctdbase.org/detail.go?type=gene&acc=54726,,,54726,OTUD4,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of OTUD4 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
28,1389456,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,56957,OTUD7B,https://ctdbase.org/detail.go?type=gene&acc=56957,,,56957,OTUD7B,10116,Rattus norvegicus (Norway rat),"2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of OTUD7B mRNA",,,PMID:23829299,https://www.ncbi.nlm.nih.gov/pubmed/23829299,23829299,,
29,1389457,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,5013,OTX1,https://ctdbase.org/detail.go?type=gene&acc=5013,,,5013,OTX1,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of OTX1 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
30,1389458,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,5016,OVGP1,https://ctdbase.org/detail.go?type=gene&acc=5016,,,5016,OVGP1,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OVGP1 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
31,1389459,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,64059,OXCT2A,https://ctdbase.org/detail.go?type=gene&acc=64059,,,64059,Oxct2a,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OXCT2A mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
32,1389460,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,339229,OXLD1,https://ctdbase.org/detail.go?type=gene&acc=339229,,,339229,OXLD1,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OXLD1 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
33,1389461,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,18459,PABPC2,https://ctdbase.org/detail.go?type=gene&acc=18459,,,18459,Pabpc2,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PABPC2 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
34,1389462,37035,Comparative Toxicogenomics Database (CTD),"2,2',3,4,4',5'-Hexachlorobiphenyl",C029790,"2,2',3',4,4',5-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C029790,67543,PABPC6,https://ctdbase.org/detail.go?type=gene&acc=67543,,,67543,Pabpc6,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PABPC6 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
35,1320904,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,23253,ANKRD12,https://ctdbase.org/detail.go?type=gene&acc=23253,,,23253,ANKRD12,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ANKRD12 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
36,1320905,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,118932,ANKRD22,https://ctdbase.org/detail.go?type=gene&acc=118932,,,118932,ANKRD22,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ANKRD22 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
37,1339956,41322,Comparative Toxicogenomics Database (CTD),Benzo(a)pyrene diol epoxide,D015123,"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide",https://ctdbase.org/detail.go?type=chem&acc=D015123,10974,ADIRF,https://ctdbase.org/detail.go?type=gene&acc=10974,,,10974,ADIRF,9606,Homo sapiens (human),"7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ADIRF mRNA",,,PMID:20382639,https://www.ncbi.nlm.nih.gov/pubmed/20382639,20382639,,
38,1387979,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429,ABCG2,9606,Homo sapiens (human),ABCG2 mRNA results in increased susceptibility to irinotecan,,,PMID:15239142,https://www.ncbi.nlm.nih.gov/pubmed/15239142,15239142,,
39,1387980,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429,ABCG2,9606,Homo sapiens (human),ABCG2 protein affects the export of irinotecan,,,PMID:15655543|PMID:15695404,https://www.ncbi.nlm.nih.gov/pubmed/15655543|https://www.ncbi.nlm.nih.gov/pubmed/15695404,15655543|15695404,,
40,1387981,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429,ABCG2,9606,Homo sapiens (human),ABCG2 protein results in decreased susceptibility to irinotecan,,,PMID:10606239|PMID:34717915,https://www.ncbi.nlm.nih.gov/pubmed/10606239|https://www.ncbi.nlm.nih.gov/pubmed/34717915,10606239|34717915,,
41,1389312,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),[irinotecan co-treated with alvocidib] results in increased activity of CASP3 protein,,,PMID:11751522,https://www.ncbi.nlm.nih.gov/pubmed/11751522,11751522,,
42,1389313,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),[irinotecan co-treated with rucaparib] results in increased expression of CASP3 protein|irinotecan results in increased expression of CASP3 protein,,,PMID:30612311,https://www.ncbi.nlm.nih.gov/pubmed/30612311,30612311,,
43,1389314,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),Irinotecan promotes the reaction [AS602868 results in increased cleavage of and results in increased activity of CASP3 protein],,,PMID:18182997,https://www.ncbi.nlm.nih.gov/pubmed/18182997,18182997,,
44,1389315,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),Irinotecan results in increased activity of CASP3 protein,,,PMID:16080519|PMID:16432164|PMID:22898888,https://www.ncbi.nlm.nih.gov/pubmed/16080519|https://www.ncbi.nlm.nih.gov/pubmed/16432164|https://www.ncbi.nlm.nih.gov/pubmed/22898888,16080519|16432164|22898888,,
45,1389316,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),RNF34 protein inhibits the reaction [irinotecan results in increased activity of CASP3 protein],,,PMID:16080519,https://www.ncbi.nlm.nih.gov/pubmed/16080519,16080519,,
46,1389317,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),Ursodeoxycholic acid promotes the reaction [irinotecan results in increased activity of CASP3 protein],,,PMID:16432164,https://www.ncbi.nlm.nih.gov/pubmed/16432164,16432164,,
47,1389318,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,837,CASP4,https://ctdbase.org/detail.go?type=gene&acc=837,,,837,CASP4,9606,Homo sapiens (human),Irinotecan results in decreased expression of CASP4 mrna|irinotecan metabolite results in decreased expression of CASP4 mRNA,,,PMID:15956246,https://www.ncbi.nlm.nih.gov/pubmed/15956246,15956246,,
48,1389319,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841,CASP8,9606,Homo sapiens (human),Irinotecan results in increased cleavage of and results in increased activity of CASP8 protein|irinotecan promotes the reaction [AS602868 results in increased cleavage of and results in increased activity of CASP8 protein],,,PMID:18182997,https://www.ncbi.nlm.nih.gov/pubmed/18182997,18182997,,
49,1389320,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841,CASP8,9606,Homo sapiens (human),Ursodeoxycholic acid promotes the reaction [irinotecan results in increased activity of CASP8 protein]|irinotecan results in increased activity of CASP8 protein,,,PMID:16432164,https://www.ncbi.nlm.nih.gov/pubmed/16432164,16432164,,
50,1389321,60838,Comparative Toxicogenomics Database (CTD),Irinotecan,D000077146,Irinotecan,https://ctdbase.org/detail.go?type=chem&acc=D000077146,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842,CASP9,9606,Homo sapiens (human),Irinotecan results in increased activity of CASP9 protein|benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [irinotecan results in increased activity of CASP9 protein]|benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [irinotecan results in increased activity of CASP9 protein],,,PMID:22898888,https://www.ncbi.nlm.nih.gov/pubmed/22898888,22898888,,
51,1388121,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,30151,ISL2B,https://ctdbase.org/detail.go?type=gene&acc=30151,,,30151,isl2b,7955,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of ISL2B mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
52,1388122,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3672,ITGA1,https://ctdbase.org/detail.go?type=gene&acc=3672,,,3672,ITGA1,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of ITGA1 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
53,1388123,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3674,ITGA2B,https://ctdbase.org/detail.go?type=gene&acc=3674,,,3674,ITGA2B,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of ITGA2B mRNA",,,PMID:20959002,https://www.ncbi.nlm.nih.gov/pubmed/20959002,20959002,,
54,1388124,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3679,ITGA7,https://ctdbase.org/detail.go?type=gene&acc=3679,,,3679,ITGA7,10116,Rattus norvegicus (Norway rat),"[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of ITGA7 mRNA",,,PMID:16984957,https://www.ncbi.nlm.nih.gov/pubmed/16984957,16984957,,
55,1388125,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,8516,ITGA8,https://ctdbase.org/detail.go?type=gene&acc=8516,,,8516,ITGA8,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of ITGA8 mRNA",,,PMID:32119087,https://www.ncbi.nlm.nih.gov/pubmed/32119087,32119087,,
56,1388126,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3689,ITGB2,https://ctdbase.org/detail.go?type=gene&acc=3689,,,3689,ITGB2,7955,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of ITGB2 mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
57,1388127,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3693,ITGB5,https://ctdbase.org/detail.go?type=gene&acc=3693,,,3693,ITGB5,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of ITGB5 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
58,1388128,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3696,ITGB8,https://ctdbase.org/detail.go?type=gene&acc=3696,,,3696,ITGB8,9606,Homo sapiens (human),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of ITGB8 mRNA",,,PMID:35618242,https://www.ncbi.nlm.nih.gov/pubmed/35618242,35618242,,
59,1388241,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,9358,ITGBL1,https://ctdbase.org/detail.go?type=gene&acc=9358,,,9358,ITGBL1,7955,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of ITGBL1 mRNA",,,PMID:28973690|PMID:35477799,https://www.ncbi.nlm.nih.gov/pubmed/28973690|https://www.ncbi.nlm.nih.gov/pubmed/35477799,28973690|35477799,,
60,1388242,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3700,ITIH4,https://ctdbase.org/detail.go?type=gene&acc=3700,,,3700,ITIH4,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of ITIH4 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
61,1388243,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,80760,ITIH5,https://ctdbase.org/detail.go?type=gene&acc=80760,,,80760,ITIH5,7955,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of ITIH5 mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
62,1388244,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3708,ITPR1,https://ctdbase.org/detail.go?type=gene&acc=3708,,,3708,ITPR1,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of ITPR1 mRNA",,,PMID:20959002,https://www.ncbi.nlm.nih.gov/pubmed/20959002,20959002,,
63,1388245,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3710,ITPR3,https://ctdbase.org/detail.go?type=gene&acc=3710,,,3710,ITPR3,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of ITPR3 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
64,1388246,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,6453,ITSN1,https://ctdbase.org/detail.go?type=gene&acc=6453,,,6453,ITSN1,9606,Homo sapiens (human),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of ITSN1 mRNA",,,PMID:23146750,https://www.ncbi.nlm.nih.gov/pubmed/23146750,23146750,,
65,1388247,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,6453,ITSN1,https://ctdbase.org/detail.go?type=gene&acc=6453,,,6453,ITSN1,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of ITSN1 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
66,1388248,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,334334,IVNS1ABPB,https://ctdbase.org/detail.go?type=gene&acc=334334,,,334334,ivns1abpb,7955,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of IVNS1ABPB mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
67,1388249,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,83700,JAM3,https://ctdbase.org/detail.go?type=gene&acc=83700,,,83700,JAM3,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of JAM3 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
68,1388361,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,558436,JMJD1CB,https://ctdbase.org/detail.go?type=gene&acc=558436,,,558436,jmjd1cb,7955,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of JMJD1CB mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
69,1388362,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,23210,JMJD6,https://ctdbase.org/detail.go?type=gene&acc=23210,,,23210,JMJD6,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of JMJD6 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
70,1388363,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,9929,JOSD1,https://ctdbase.org/detail.go?type=gene&acc=9929,,,9929,JOSD1,10090,Mus musculus (house mouse),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of JOSD1 mRNA",,,PMID:23994337,https://www.ncbi.nlm.nih.gov/pubmed/23994337,23994337,,
71,1388364,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,90861,JPT2,https://ctdbase.org/detail.go?type=gene&acc=90861,,,90861,JPT2,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of JPT2 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
72,1388365,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725,JUN,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of JUN mRNA",,,PMID:19692669,https://www.ncbi.nlm.nih.gov/pubmed/19692669,19692669,,
73,1388366,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725,JUN,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of JUN mRNA",,,PMID:20959002,https://www.ncbi.nlm.nih.gov/pubmed/20959002,20959002,,
74,1388367,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725,JUN,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of JUN protein",,,PMID:16081525,https://www.ncbi.nlm.nih.gov/pubmed/16081525,16081525,,
75,1388368,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3727,JUND,https://ctdbase.org/detail.go?type=gene&acc=3727,,,3727,JUND,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of JUND mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
76,1388493,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,7994,KAT6A,https://ctdbase.org/detail.go?type=gene&acc=7994,,,7994,KAT6A,7955,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of KAT6A mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
77,1388494,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3739,KCNA4,https://ctdbase.org/detail.go?type=gene&acc=3739,,,3739,KCNA4,7955,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of KCNA4 mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
78,1388495,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3752,KCND3,https://ctdbase.org/detail.go?type=gene&acc=3752,,,3752,KCND3,7955,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of KCND3 mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
79,1388496,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3752,KCND3,https://ctdbase.org/detail.go?type=gene&acc=3752,,,3752,KCND3,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of KCND3 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
80,1388497,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3757,KCNH2,https://ctdbase.org/detail.go?type=gene&acc=3757,,,3757,KCNH2,9606,Homo sapiens (human),"3,4,5,3',4'-pentachlorobiphenyl affects the activity of KCNH2 protein",,,PMID:22676973,https://www.ncbi.nlm.nih.gov/pubmed/22676973,22676973,,
81,1388498,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,131096,KCNH8,https://ctdbase.org/detail.go?type=gene&acc=131096,,,131096,KCNH8,7955,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of KCNH8 mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
82,1388499,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,30820,KCNIP1,https://ctdbase.org/detail.go?type=gene&acc=30820,,,30820,KCNIP1,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of KCNIP1 mRNA",,,PMID:32119087,https://www.ncbi.nlm.nih.gov/pubmed/32119087,32119087,,
83,1388500,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3768,KCNJ12,https://ctdbase.org/detail.go?type=gene&acc=3768,,,3768,KCNJ12,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of KCNJ12 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
84,1388501,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3759,KCNJ2,https://ctdbase.org/detail.go?type=gene&acc=3759,,,3759,KCNJ2,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of KCNJ2 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
85,1388614,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,570401,KCNN1B,https://ctdbase.org/detail.go?type=gene&acc=570401,,,570401,kcnn1b,7955,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of KCNN1B mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
86,1388615,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3785,KCNQ2,https://ctdbase.org/detail.go?type=gene&acc=3785,,,3785,KCNQ2,7955,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of KCNQ2 mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
87,1388616,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3787,KCNS1,https://ctdbase.org/detail.go?type=gene&acc=3787,,,3787,KCNS1,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of KCNS1 mRNA",,,PMID:32119087,https://www.ncbi.nlm.nih.gov/pubmed/32119087,32119087,,
88,1388617,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,27012,KCNV1,https://ctdbase.org/detail.go?type=gene&acc=27012,,,27012,KCNV1,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of KCNV1 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
89,1388618,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,100003413,KDM4AA,https://ctdbase.org/detail.go?type=gene&acc=100003413,,,100003413,kdm4aa,7955,Danio rerio (zebrafish),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of KDM4AA mRNA",,,PMID:28973690,https://www.ncbi.nlm.nih.gov/pubmed/28973690,28973690,,
90,1388619,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,23030,KDM4B,https://ctdbase.org/detail.go?type=gene&acc=23030,,,23030,KDM4B,9606,Homo sapiens (human),"ESR1 protein promotes the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of KDM4B mrna]|3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [ESR1 protein binds to KDM4B intron]|kdm4b protein promotes the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of IL6 mrna]|3,4,5,3',4'-pentachlorobiphenyl results in increased expression of KDM4B mrna|3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [KDM4B protein binds to RELA promoter]|kdm4b protein promotes the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of RELA mrna]",,,PMID:26519613,https://www.ncbi.nlm.nih.gov/pubmed/26519613,26519613,,
91,1388974,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,89953,KLC4,https://ctdbase.org/detail.go?type=gene&acc=89953,,,89953,KLC4,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of KLC4 mRNA",,,PMID:32119087,https://www.ncbi.nlm.nih.gov/pubmed/32119087,32119087,,
92,1388975,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,7071,KLF10,https://ctdbase.org/detail.go?type=gene&acc=7071,,,7071,KLF10,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of KLF10 mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
93,1389463,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3929,LBP,https://ctdbase.org/detail.go?type=gene&acc=3929,,,3929,LBP,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LBP mRNA",,,PMID:19692669|PMID:20959002,https://www.ncbi.nlm.nih.gov/pubmed/19692669|https://www.ncbi.nlm.nih.gov/pubmed/20959002,19692669|20959002,,
94,1389464,63090,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5-Pentachlorobiphenyl",C023035,"3,4,5,3',4'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C023035,3930,LBR,https://ctdbase.org/detail.go?type=gene&acc=3930,,,3930,LBR,10116,Rattus norvegicus (Norway rat),"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LBR mRNA",,,PMID:23196670,https://www.ncbi.nlm.nih.gov/pubmed/23196670,23196670,,
95,1375223,72303,Comparative Toxicogenomics Database (CTD),Honokiol,C005499,honokiol,https://ctdbase.org/detail.go?type=chem&acc=C005499,2554,GABRA1,https://ctdbase.org/detail.go?type=gene&acc=2554,,,2554,GABRA1,9606,Homo sapiens (human),Honokiol results in increased activity of [GABRA1 protein binds to GABRB3 protein]|[diazepam co-treated with honokiol] results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]|honokiol results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]|honokiol results in increased activity of [GABRA1 protein binds to GABRB2 protein],,,PMID:21699169,https://www.ncbi.nlm.nih.gov/pubmed/21699169,21699169,,
96,1375224,72303,Comparative Toxicogenomics Database (CTD),Honokiol,C005499,honokiol,https://ctdbase.org/detail.go?type=chem&acc=C005499,2555,GABRA2,https://ctdbase.org/detail.go?type=gene&acc=2555,,,2555,GABRA2,9606,Homo sapiens (human),Honokiol results in increased activity of [GABRA2 protein binds to GABRB2 protein],,,PMID:21699169,https://www.ncbi.nlm.nih.gov/pubmed/21699169,21699169,,
97,1388129,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,8870,IER3,https://ctdbase.org/detail.go?type=gene&acc=8870,,,8870,IER3,9606,Homo sapiens (human),Perfluorooctane sulfonic acid results in increased expression of IER3 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
98,1388502,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458,IFNG,10090,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in decreased expression of IFNG protein,,,PMID:23237827,https://www.ncbi.nlm.nih.gov/pubmed/23237827,23237827,,
99,1388620,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,90410,IFT20,https://ctdbase.org/detail.go?type=gene&acc=90410,,,90410,IFT20,9606,Homo sapiens (human),Perfluorooctane sulfonic acid results in increased expression of IFT20 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
100,1388621,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,90410,IFT20,https://ctdbase.org/detail.go?type=gene&acc=90410,,,90410,IFT20,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of IFT20 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
101,1388622,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,112752,IFT43,https://ctdbase.org/detail.go?type=gene&acc=112752,,,112752,IFT43,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of IFT43 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
102,1389128,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,107605,RDH1,https://ctdbase.org/detail.go?type=gene&acc=107605,,,107605,Rdh1,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of RDH1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
103,1389129,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,157506,RDH10,https://ctdbase.org/detail.go?type=gene&acc=157506,,,157506,RDH10,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of RDH10 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of RDH10 mrna|[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of RDH10 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
104,1448768,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,3312,HSPA8,https://ctdbase.org/detail.go?type=gene&acc=3312,,,3312,HSPA8,9606,Homo sapiens (human),Thifluzamide results in increased expression of HSPA8 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
105,1387833,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5443,POMC,https://ctdbase.org/detail.go?type=gene&acc=5443,,,5443,POMC,10090,Mus musculus (house mouse),POMC protein affects the reaction [nicotine results in increased abundance of dopamine],,,PMID:15689546,https://www.ncbi.nlm.nih.gov/pubmed/15689546,15689546,,
106,1387834,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5443,POMC,https://ctdbase.org/detail.go?type=gene&acc=5443,,,5443,POMC,10090,Mus musculus (house mouse),POMC protein affects the susceptibility to nicotine,,,PMID:19376143,https://www.ncbi.nlm.nih.gov/pubmed/19376143,19376143,,
107,1387835,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5443,POMC,https://ctdbase.org/detail.go?type=gene&acc=5443,,,5443,POMC,10116,Rattus norvegicus (Norway rat),Nicotine affects the expression of POMC protein,,,PMID:22975262,https://www.ncbi.nlm.nih.gov/pubmed/22975262,22975262,,
108,1387836,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5443,POMC,https://ctdbase.org/detail.go?type=gene&acc=5443,,,5443,POMC,10116,Rattus norvegicus (Norway rat),Nicotine results in decreased expression of POMC protein,,,PMID:28555334,https://www.ncbi.nlm.nih.gov/pubmed/28555334,28555334,,
109,1387837,89594,Comparative Toxicogenomics Database (CTD),Nicotine,D009538,Nicotine,https://ctdbase.org/detail.go?type=chem&acc=D009538,5443,POMC,https://ctdbase.org/detail.go?type=gene&acc=5443,,,5443,POMC,10116,Rattus norvegicus (Norway rat),Nicotine results in increased expression of POMC protein alternative form,,,PMID:23623838,https://www.ncbi.nlm.nih.gov/pubmed/23623838,23623838,,
110,1372950,91144,Comparative Toxicogenomics Database (CTD),"5,7-Dihydroxy-2-(4-hydroxyphenyl)-6,8-dimethylchroman-4-one",C015881,farrerol,https://ctdbase.org/detail.go?type=chem&acc=C015881,1029,CDKN2A,https://ctdbase.org/detail.go?type=gene&acc=1029,,,1029,CDKN2A,9606,Homo sapiens (human),Farrerol results in increased expression of CDKN2A protein|farrerol results in increased expression of CDKN2A mRNA,,,PMID:35833306,https://www.ncbi.nlm.nih.gov/pubmed/35833306,35833306,,
111,1387982,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,2681,GGTA1,https://ctdbase.org/detail.go?type=gene&acc=2681,,,2681,GGTA1,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of GGTA1 mRNA",,,PMID:23146750,https://www.ncbi.nlm.nih.gov/pubmed/23146750,23146750,,
112,1387983,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,14599,GH,https://ctdbase.org/detail.go?type=gene&acc=14599,,,14599,Gh,10090,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of GH mrna|[2,2',4,4'-tetrabromodiphenyl ether co-treated with thyroxine] results in increased expression of GH mRNA",,,PMID:27420076,https://www.ncbi.nlm.nih.gov/pubmed/27420076,27420076,,
113,1387984,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,2689,GH2,https://ctdbase.org/detail.go?type=gene&acc=2689,,,2689,GH2,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of GH2 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
114,1387985,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,2691,GHRH,https://ctdbase.org/detail.go?type=gene&acc=2691,,,2691,GHRH,7955,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of GHRH mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
115,1387986,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,100002189,GHRHR2,https://ctdbase.org/detail.go?type=gene&acc=100002189,,,100002189,ghrhr2,7955,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of GHRHR2 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
116,1387987,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,2693,GHSR,https://ctdbase.org/detail.go?type=gene&acc=2693,,,2693,GHSR,10090,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of GHSR mrna|esr1 gene mutant form inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of GHSR mrna]|2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of GHSR mRNA",,,PMID:29112739,https://www.ncbi.nlm.nih.gov/pubmed/29112739,29112739,,
117,1387988,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,55303,GIMAP4,https://ctdbase.org/detail.go?type=gene&acc=55303,,,55303,GIMAP4,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of GIMAP4 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
118,1502806,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,6633,SNRPD2,https://ctdbase.org/detail.go?type=gene&acc=6633,,,6633,SNRPD2,10090,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of SNRPD2 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
119,1398235,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,286204,CRB2,https://ctdbase.org/detail.go?type=gene&acc=286204,,,286204,CRB2,9606,Homo sapiens (human),Fulvestrant results in increased expression of CRB2 mrna|cadmium inhibits the reaction [fulvestrant results in increased expression of CRB2 mrna],,,PMID:31646340,https://www.ncbi.nlm.nih.gov/pubmed/31646340,31646340,,
120,1387694,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,14728,LILRB4A,https://ctdbase.org/detail.go?type=gene&acc=14728,,,14728,Lilrb4a,10090,Mus musculus (house mouse),Epoxiconazole results in increased expression of LILRB4A mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
121,1387695,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,51474,LIMA1,https://ctdbase.org/detail.go?type=gene&acc=51474,,,51474,LIMA1,10090,Mus musculus (house mouse),Epoxiconazole results in decreased expression of LIMA1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
122,1387696,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,55679,LIMS2,https://ctdbase.org/detail.go?type=gene&acc=55679,,,55679,LIMS2,10090,Mus musculus (house mouse),Epoxiconazole results in decreased expression of LIMS2 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
123,1388786,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,5609,MAP2K7,https://ctdbase.org/detail.go?type=gene&acc=5609,,,5609,MAP2K7,10090,Mus musculus (house mouse),Epoxiconazole results in decreased expression of MAP2K7 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
124,1388787,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,4214,MAP3K1,https://ctdbase.org/detail.go?type=gene&acc=4214,,,4214,MAP3K1,10090,Mus musculus (house mouse),Epoxiconazole results in increased expression of MAP3K1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
125,1388788,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,4294,MAP3K10,https://ctdbase.org/detail.go?type=gene&acc=4294,,,4294,MAP3K10,10090,Mus musculus (house mouse),Epoxiconazole results in decreased expression of MAP3K10 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
126,1388789,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,4293,MAP3K9,https://ctdbase.org/detail.go?type=gene&acc=4293,,,4293,MAP3K9,10090,Mus musculus (house mouse),Epoxiconazole results in increased expression of MAP3K9 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
127,1388790,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,11184,MAP4K1,https://ctdbase.org/detail.go?type=gene&acc=11184,,,11184,MAP4K1,10090,Mus musculus (house mouse),Epoxiconazole results in decreased expression of MAP4K1 mRNA,,,PMID:35436446,https://www.ncbi.nlm.nih.gov/pubmed/35436446,35436446,,
128,1389623,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,5876,RABGGTB,https://ctdbase.org/detail.go?type=gene&acc=5876,,,5876,RABGGTB,9606,Homo sapiens (human),Deguelin results in increased expression of RABGGTB mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
129,1387830,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,8312,AXIN1,https://ctdbase.org/detail.go?type=gene&acc=8312,,,8312,AXIN1,9606,Homo sapiens (human),Tamibarotene results in increased expression of AXIN1 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
130,1387831,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,51582,AZIN1,https://ctdbase.org/detail.go?type=gene&acc=51582,,,51582,AZIN1,9606,Homo sapiens (human),Tamibarotene affects the expression of AZIN1 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
131,1387832,108143,Comparative Toxicogenomics Database (CTD),Tamibarotene,C061133,tamibarotene,https://ctdbase.org/detail.go?type=chem&acc=C061133,566,AZU1,https://ctdbase.org/detail.go?type=gene&acc=566,,,566,AZU1,9606,Homo sapiens (human),Tamibarotene results in increased expression of AZU1 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
132,1960495,11156785,BindingDB,"Succinamide peptidomimetic, 12",19646,(2R)-2-(cyclohexylmethyl)-N-[(2S)-3-methyl-1-{[4-(trifluoromethoxy)phenyl]amino}butan-2-yl]-4-(morpholin-4-yl)-4-oxobutanamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=19646,5580,Cathepsin S,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5580,P25774,Cathepsin S,1520,CTSS,9606,Homo sapiens (human),,Ki (nM),11.0,PMID:17382545|DOI:10.1016/j.bmcl.2007.02.049,https://www.ncbi.nlm.nih.gov/pubmed/17382545|https://doi.org/10.1016/j.bmcl.2007.02.049,17382545,10.1016/j.bmcl.2007.02.049,
133,1986970,23672308,Comparative Toxicogenomics Database (CTD),Monosodium Glutamate,D012970,Sodium Glutamate,https://ctdbase.org/detail.go?type=chem&acc=D012970,374291,NDUFS7,https://ctdbase.org/detail.go?type=gene&acc=374291,,,374291,NDUFS7,10090,Mus musculus (house mouse),[sodium glutamate co-treated with trans fatty acids] results in increased expression of NDUFS7 mRNA,,,PMID:19001666,https://www.ncbi.nlm.nih.gov/pubmed/19001666,19001666,,
